Large Scale Tissue Microarray Production by ArraysBank

Arrays Bank is a premier biospecimen provider maintaining a extensive repository of over 2 million human and animal tissue samples, carefully collected, processed, and preserved to support advanced biomedical research. With a strong commitment to scientific integrity and strict quality standards, the company plays a essential role in advancing clinical translation studies, drug discovery, diagnostic innovation, and personalized medicine. By offering access to a broad range of formalin-fixed, paraffin-embedded (FFPE) tissue samples, the company empowers researchers, laboratories, and pharmaceutical organizations to streamline their studies with high-quality materials. tissue block

FFPE tissue samples are widely recognized as a industry benchmark in pathology and molecular research due to their long-term stability and preservation of cellular morphology. ArraysBank specializes in supplying high-quality FFPE tissue specimens, including TMAs, paraffin blocks, tissue sections, and molecular detection blocks. Each sample is processed under strict quality assurance protocols to ensure consistency, traceability, and reproducibility. The preservation method maintains the structural integrity of tissues while allowing for downstream applications such as IHC testing, DNA and RNA extraction, ISH, and other molecular diagnostics.

One of the key strengths of ArraysBank lies in its extensive collection of TMAs. Tissue microarrays enable researchers to analyze multiple tissue samples at the same time on a single slide, making them an efficient and economical tool for high-throughput studies. These arrays are particularly valuable in oncology studies, marker verification, and comparative disease analysis. By offering diverse panels representing various clinical stages, tissue types, and demographic backgrounds, ArraysBank ensures that investigators have access to robust datasets that support data-driven scientific conclusions.

In addition to tissue microarrays, the supplier provides paraffin tissue blocks and tissue sections tailored to individual research requirements. Tissue blocks allow laboratories to perform customized sectioning and staining protocols according to their experimental needs, while pre-prepared tissue sections offer convenience and immediate usability. Diagnostic-ready blocks are also available, optimized for complex testing and molecular testing applications. This flexibility ensures that researchers can select the most appropriate format for their experimental design without compromising on accuracy or performance.

What truly distinguishes this biospecimen provider from other tissue suppliers is the comprehensiveness of clinical and experimental data linked to its specimens. Many of the available samples come with detailed treatment history, outcome statistics, and immunohistochemical marker data. Access to treatment history allows researchers to connect molecular findings with clinical responses, contributing to the development of precision treatments and improved clinical decision-making. Survival data enhances prognostic studies by enabling extended outcome analysis, while IHC marker data supports marker identification and validation efforts. This comprehensive approach closes the gap between laboratory research and real-world applications.

The company’s repository includes samples representing a wide range of medical conditions, organ systems, and animal models, making it a versatile resource for both human and veterinary research. The inclusion of animal tissue samples supports early-stage studies and cross-species analysis, offering valuable insights into pathological processes and treatment responses. By maintaining strict ethical sourcing standards and regulatory compliance, the organization ensures that all specimens are collected and distributed responsibly, adhering to global ethical standards.

Quality assurance is a cornerstone of the company’s workflow. Each specimen undergoes rigorous pathological review and documentation to confirm diagnosis, tissue integrity, and suitability for research use. Uniform processing methods reduce variability and enhance reproducibility across studies. This commitment to quality gives researchers confidence in the reliability of the materials they receive, ultimately contributing to more precise and impactful scientific discoveries.

As biomedical research continues to evolve toward precision medicine and personalized treatment strategies, access to well-validated, well-annotated tissue samples becomes increasingly important. ArraysBank stands at the forefront of this movement by providing an carefully curated biospecimen library supported by comprehensive clinical data. With more than two million human and animal tissue samples available, along with specialized expertise in FFPE tissue products, ArraysBank serves as a trusted partner for researchers striving to advance medical knowledge and improve patient outcomes worldwide.